By MSYPN member Reese Garcia | The Rocky Mountain MS Center and MSYPN are great avenues for raising your voice and sharing your story. Recently through the MSYPN, I had…
Read More
Results from a recent study conducted at the Rocky Mountain MS Center at University of Colorado examining cannabis use by patients with multiple sclerosis were published recently in the Multiple…
By Becky Post, Becky Post, CTRS, Certified Therapeutic Recreation Specialist, Adventure Recreation Coordinator, King Adult Day Enrichment Program This month’s article highlights KADEP’s Adventure Recreation Day Trips. With day trips,…
International consensus on quality standards for brain health-focused care in multiple sclerosis have been published in the Multiple Sclerosis Journal this month. Dr. Timothy Vollmer, Medical Director at the Rocky…
Interview with Dr. Jeffrey Hebert, Associate Professor, Physical Medicine & Rehabilitation-Physical Therapy Program RMMSC: Could you please give us a brief overview of the PCORI study on MS and exercise? Dr….
By Becky Post, Certified Therapeutic Recreation Specialist, Adventure Recreation Coordinator at RMMSC’s King Adult Day Enrichment Program The RMMSC’s King Adult Day Enrichment Program (KADEP) offers several outing opportunities for…
This week, the results from a clinical trial of 250 participants with progressive MS were released and showed that ibudilast on had a significant impact in slowing down brain volume…
This past month, the MSYPN met with RMMSC Board Chair, Del Arnold, and Board Member, Erica Tarpey. Del and Erica discussed their careers, what led them to the RMMSC board, and…
An Interview with Dr. Roger Enoka with the Neurophysiology of Movement Laboratory at University of Colorado Boulder campus Dr. Roger Enoka, a professor at the University of Colorado Boulder, has…
Quite a bit’s going on in the world of disease modifying therapies (DMTs), and we’ve prepared a brief update for you. Read on for more about Gilenya’s FDA approval for…